Neoplasms: all 9,617 studies

Page 50 of 97. Open to participants first (2,509), then studies with results posted, then the rest; newest registration first within each.

• Patient Reported Outcomes by Patients With Metastatic Renal Cell CarcinomaStatus unknownNCT05135832Not applicable
• Percutaneous Laparoscopy for Ovarian Tissue Cryopreservation.CompletedNCT05134090
• Therapeutic Dose Monitoring (TDM) of TamoxifenStatus unknownNCT05133674Phase 2
• Cannabis Use Patterns Among Cancer PatientsCompletedNCT05132842
• Cardiac Autonomic Dysfunction in Childhood Cancer SurvivorsWithdrawnNCT05132673
• The BurnAlong Pilot Study for Adolescent and Young Adult Cancer SurvivorsCompletedNCT05131815Not applicable
• Stratification of Patients in Oncogeriatrics and Personalization of InterventionsCompletedNCT05131113Not applicable
• A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Anti-tumor Activity of RO7444973 in Participants With Unresectable and/or Metastatic MAGE-A4-positive Solid TumorsTerminatedNCT05129280Phase 1
• A Study Explore JS001+JS002 in Patients With Advanced CancerTerminatedNCT05128539Phase 1
• A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid TumorsCompletedNCT05126927Early Phase 1
• Efficacy of a Combined ACT+ App Intervention to Improve Psychological Flexibility and Associated Symptoms in Cancer PatientsActive, not recruitingNCT05126823Not applicable
• A Study of Sirolimus for Injection (Albumin Bound) in Patients With Advanced Solid TumorsStatus unknownNCT05125523Phase 1
• Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic DevicesActive, not recruitingNCT05124405Not applicable
• Demonstration Of A Next Generation PET CT SystemStatus unknownNCT05122715Not applicable
• RT-01 Monotherapy and in Combination With Nivolumab in Patients With Advanced Solid TumorsStatus unknownNCT05122572Phase 1
• Effect of Gender on Distress and Fatigue in Cancer PatientsCompletedNCT05122052
• Local Anesthesia Versus Combined Local Anesthesia With Single Dose Analgesia on Pain Control During Thoracic Ultrasound Guided ProceduresStatus unknownNCT05121233Phase 4
• A Phase I Study of IBI325 in Patients With Advanced Solid TumorCompletedNCT05119998Phase 1
• A Phase 1/2, Study of YL-15293 in Subjects With Advanced Solid Tumors With a KRAS G12C MutationStatus unknownNCT05119933Phase 1/2
• Dose-Escalation and Dose-Expansion Study of ZX-4081 in Patients With Advanced Solid TumorsStatus unknownNCT05118841Phase 1
• Measuring the Impact of MANNA s Medically Tailored Meal Program in Patients With a Non-terminal Cancer DiagnosisCompletedNCT05118802
• Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid TumorsCompletedNCT05116709Phase 1
• A Study to Evaluate the Safety and Efficacy of Docetaxel for Injection (Albumin-bound)in Different Dose Regimens in Patients With Advanced Solid TumorsStatus unknownNCT05114915Phase 1
• Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid TumoursCompletedNCT05114668Phase 1
• Chidamide Plus Sintilimab for Chemotherapy-refractory Advanced High-grade Neuroendocrine NeoplasmStatus unknownNCT05113355Phase 2
• Virtual Dignity Therapy for Palliative Care Patients With Advanced CancerCompletedNCT05113199Not applicable
• Transvaginal Versus Transabdominal Extraction of Laparoscopically-excised SpecimenCompletedNCT05113134Not applicable
• An Extension Study in Participants Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study (IMbrella C)Active, not recruitingNCT05112965Phase 3
• Effect of Shock Wave In Reducing Chemotherapy- Induced Peripheral Neuropathy In Adult and Pediatric Tumors PatientsStatus unknownNCT05111730Not applicable
• A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant TumorsStatus unknownNCT05110807Phase 1
• Evaluation of the Synergistic Impact of Needle and Forceps Biopsy With Electromagnetic Navigation BronchoscopyActive, not recruitingNCT05110131Not applicable
• QLF32004 Injection for the Treatment of Patients With Advanced Malignant TumorsStatus unknownNCT05108779Phase 1
• A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid TumorsCompletedNCT05108623Phase 1
• PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell MalignanciesTerminatedNCT05107856Phase 1
• Afatinib (GILOTRIF®) in Patients Suffering From Tumors Harboring Neuregulin 1 (NRG1) Gene Alterations (Specifically NRG1 Gene Fusion-positive Advanced Solid Tumors)No longer availableNCT05107193
• Phase I/II Clinical Trial of LBL-015 for InjectionCompletedNCT05107011Phase 1/2
• Study of a New Medical Device for Oral MucositisWithdrawnNCT05104268Early Phase 1
• Impact of Donor-recipient ABO Matching on Haploidentical Stem Cell TransplantationCompletedNCT05103995
• A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant TumorsCompletedNCT05102006Phase 1/2
• Study to Evaluate the Safety and Tolerability of ABL501, and to Determine the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D) of ABL501 in Subjects With Any Progressive, Locally Advanced (Unresectable) or Metastatic Solid TumorsCompletedNCT05101109Phase 1
• Safety, Tolerability, and Anti-Tumor Activity of AFM24 in Combination With SNK01 in Subjects With Advanced/Metastatic EGFR-Expressing CancersTerminatedNCT05099549Phase 1/2
• 3D011-08 Monotherapy in Subjects With Advanced Solid TumorsWithdrawnNCT05099536Phase 1
• Local Radiotherapy in Combination With Immunotherapy in Advanced Solid Tumors PatientsStatus unknownNCT05097781Phase 2
• Perioperative Encobini in BRAFV600 Mutant Stage III (B/C/D) or Oligometastatic Stage IV MelanomaActive, not recruitingNCT05097378Phase 2
• Esketamine Combined With Pregabalin on Acute Postoperative Pain in Patients Undergoing Resection of Spinal Neoplasms.CompletedNCT05096468Phase 2/3
• EUS Shear Wave for Solid Pancreatic Lesions.Status unknownNCT05095831
• A Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Malignant TumorSuspendedNCT05089461Phase 2
• Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid TumorsCompletedNCT05088070Phase 1
• A Study of Irinotecan Hydrochloride Liposome in Combination With 5-FU/LV in Advanced Solid TumorsCompletedNCT05086848Phase 1
• A Study of Irinotecan Hydrochloride Liposome in Advanced Solid TumorsCompletedNCT05086822Phase 1
• Examining a Training Program for for Acute Lymphoblastic Leukemia Childhood Cancer SurvivorsCompletedNCT05086354Not applicable
• Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCTStatus unknownNCT05084027Phase 2
• Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative ChemotherapyCompletedNCT05083338
• A Study of HMBD-002, a Monoclonal Antibody Targeting VISTA, as Monotherapy and Combined With Pembrolizumab, in Patients With Advanced Solid TumorsCompletedNCT05082610Phase 1
• Liposomal Bupivacaine in Benign Soft Tissue Tumor ResectionStatus unknownNCT05082441Phase 4
• Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS TumorsTerminatedNCT05081180Phase 1
• How to Carry on an Effective Community Program of Exercice-oncology.CompletedNCT05078216
• IMM2902, a HER2/SIRPα Bispecific MAb-Trap Antibody-receptor Fusion Protein, in Patients with HER2-expressing Advanced Solid TumorsSuspendedNCT05076591Phase 1
• A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of Oral TACH101 in Participants With Advanced or Metastatic CancerActive, not recruitingNCT05076552Phase 1
• PM14 Administered Intravenously to Patients With Advanced Solid TumorsCompletedNCT05076396Phase 1
• Clinical Value of Next Generation Sequencing in Chinese Childhood Solid TumorsStatus unknownNCT05076071
• A Study of ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT05075564Phase 1
• A Study of SKLB1028 in Patients With Advanced Solid TumorStatus unknownNCT05072522Phase 1
• Genetic Overlap Between Anomalies and Cancer in Kids in the Children's Oncology Group: The COG GOBACK StudyActive, not recruitingNCT05071859
• FT538 in Combination With Monoclonal Antibodies in Advanced Solid TumorsTerminatedNCT05069935Phase 1
• Peroperative Assessment of Malignancies of the Head and Neck Using High-resolution 18F-FDG-PET/CTCompletedNCT05068687Not applicable
• Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsStatus unknownNCT05068180Phase 4
• Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic CancerTerminatedNCT05065736Early Phase 1
• A Study of ZL-1211 in Patients With Advanced Solid TumorCompletedNCT05065710Phase 1
• Exercise as Medicine for People With Cancer SwedenCompletedNCT05064670Not applicable
• TheraSphere With Durvalumab and Tremelimumab for HCCActive, not recruitingNCT05063565Phase 2
• Stereotactic Body Radiotherapy Followed by Surgical Stabilization in Spinal MetastasesWithdrawnNCT05060653Not applicable
• Use of Google Translate to Enhance Patient Pain and Nausea Assessment and Satisfaction After General AnesthesiaCompletedNCT05060328
• Study to Assess an Anti-Trop2 Antibody Drug Conjugate in Relapsed or Refractory Solid TumorsWithdrawnNCT05060276Phase 1
• Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian CancerStatus unknownNCT05059782Not applicable
• A Study of HS269 in Patients With Advanced Solid TumorsStatus unknownNCT05058352Phase 1
• Distress Associated with Coronavirus Disease 2019 and Telehealth on Supportive Care Patients with Advanced CancerCompletedNCT05058339
• PRecision Oncology Evidence Development in Cancer Treatment - LiquidActive, not recruitingNCT05057234Not applicable
• Multicomponent Physical Activity Intervention for the Reduction of Psychosocial Distress in Cancer PatientsTerminatedNCT05056831Not applicable
• Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain MetastasesCompletedNCT05054998Phase 4
• First-in-human Study of IO-108 as Single Agent and in Combination With a PD-1 Immune Check Point Inhibitor in Patients With Advanced Solid TumorsCompletedNCT05054348Phase 1
• A Study to Evaluate Safety and Efficacy of ACT001 and Anti-PD-1 in Patients With Surgically Accessible Recurrent Glioblastoma MultiformeActive, not recruitingNCT05053880Phase 1/2
• Understanding the Risk of Blood Clots and Bleeding in Patients With Hematological Malignancies, HAT StudyCompletedNCT05053100
• Evaluating a New Gonadotoxic Risk Stratification SystemWithdrawnNCT05052632
• PARASTOP - Paracetamol With Strong OpioidsCompletedNCT05051735Phase 3
• Intra-tumor Injection of Oncolytic Viruses H101 Combined With or Without Radiotherapy in Refractory/Recurrent Gynecological MalignanciesActive, not recruitingNCT05051696Phase 2
• Clinical Study of JS007 in Patients With Advanced Solid TumorsStatus unknownNCT05049265Phase 1
• Biomarkers Predictive for Cervical Intraepithelial Neoplasia Grade 2 (CIN2) EvolvementActive, not recruitingNCT05049252
• 18F-FACBC PET/CT and the PSA Kinetics for PCa Patients With Biochemical Recurrence.Status unknownNCT05048537Not applicable
• A Clinical Study of 6MW3211 Injection in the Treatment of Advanced Malignant NeoplasmStatus unknownNCT05048160Phase 1/2
• A Phase I Study of HRS2300 or Combined With SHR-1316 or SHR-1701 or Trametinib or Almonertinib in Patients With Advanced MalignanciesTerminatedNCT05048134Phase 1
• A Feasibility Study of a Virtual Rehabilitation and Physical Activity Program for People With Advanced CancerCompletedNCT05047042Not applicable
• A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3811 Tablets in Patients With Advanced Malignant TumorsStatus unknownNCT05046847Phase 1
• Decreasing Polypharmacy in Older Adults With Curable Cancers TrialCompletedNCT05046171Phase 1/2
• The Durability of Protection and Immuno-persistence Study of a Recombinant HPV 16/18 Bivalent Vaccine in FemaleStatus unknownNCT05045755
• Evaluation of LBL-003 Phase I Study in Patients With Advanced MalignanciesCompletedNCT05042908Phase 1
• ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)WithdrawnNCT05041972Phase 2
• Wet Heparinized Suction for Abdominal CancerWithdrawnNCT05041335Not applicable
• Study of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic MalignancyCompletedNCT05040932Phase 1
• SI-B001 as a Single Agent or in Combination With Chemotherapy in the Treatment of Digestive System MalignanciesTerminatedNCT05039944Phase 2

← Neoplasms overview